The Japanese group’s NS Pharma subsidiary has ... exon-skipping DMD therapies Exondys 51 (eteplirsen) and Amondys 45 (casimersen) collectively brought in around $950 million.
R.Park, A.R.Allen, C.B.Brown, R.Chahayed, O.Fedi, P.M.Lawrence II, Bruno Mars, T.M.Thomas, H.R.Walter, M.D.Chapman, N.Chinn Bruno Mars, Cirkut, O.Fedi, R.Chahayed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback